Publications

Found 1 results
Filters: Author is X. Li  [Clear All Filters]
2012
J. Liu, Li, X., Yu, N., Yang, Y. - Q., Li, X., Ye, Z. - Y., and Li, J. - C., Genetic instability and CpG methylation in the 5'-flanking region of the PAI-1 gene in Chinese patients with gastric cancer, vol. 11, pp. 2899-2908, 2012.
Andreasen PA, Egelund R and Petersen HH (2000). The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol. Life Sci. 57: 25-40. http://dx.doi.org/10.1007/s000180050497 PMid:10949579   Baylin SB and Herman JG (2000). DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16: 168-174. http://dx.doi.org/10.1016/S0168-9525(99)01971-X   Chakrabarti S, Sengupta S, Sengupta A, Basak SN, et al. (2006). Genomic instabilities in squamous cell carcinoma of head and neck from the Indian population. Mol. Carcinog. 45: 270-277. http://dx.doi.org/10.1002/mc.20178 PMid:16402388   Durand MK, Bodker JS, Christensen A, Dupont DM, et al. (2004). Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thromb. Haemost. 91: 438-449. PMid:14983218   Esteller M (2003). Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv. Exp. Med. Biol. 532: 39-49. http://dx.doi.org/10.1007/978-1-4615-0081-0_5 PMid:12908548   Gao S, Skeldal S, Krogdahl A, Sorensen JA, et al. (2005). CpG methylation of the PAI-1 gene 5'-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines. Thromb. Haemost. 94: 651-660. PMid:16268485   Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, et al. (1995). Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55: 4531-4535. PMid:7553622   Gopalan V, Smith RA, Nassiri MR, Yasuda K, et al. (2010). GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features. Hum. Pathol. 41: 1009-1015. http://dx.doi.org/10.1016/j.humpath.2009.11.014 PMid:20236690   Jemal A, Siegel R, Ward E, Hao Y, et al. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58: 71-96. http://dx.doi.org/10.3322/CA.2007.0010 PMid:18287387   Juvan R, Hudler P, Gazvoda B, Repse S, et al. (2007). Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma. Croat. Med. J. 48: 207-217. PMid:17436385 PMCid:2080507   Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, et al. (1999). In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl. Acad. Sci. U. S. A. 96: 12754-12759. http://dx.doi.org/10.1073/pnas.96.22.12754 PMid:10535995 PMCid:23084   Ozisik YY, Meloni AM, Surti U and Sandberg AA (1993). Deletion 7q22 in uterine leiomyoma. A cytogenetic review. Cancer Genet. Cytogenet. 71: 1-6. http://dx.doi.org/10.1016/0165-4608(93)90195-R   Sakakibara T, Hibi K, Koike M, Fujiwara M, et al. (2006). Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci. 97: 395-399. http://dx.doi.org/10.1111/j.1349-7006.2006.00185.x PMid:16630137   Sato N, Fukushima N, Maitra A, Matsubayashi H, et al. (2003). Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 63: 3735-3742. PMid:12839967   Sourla A, Polychronakos C, Zeng WR, Nepveu A, et al. (1996). Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas. Cancer Res. 56: 3123-3128. PMid:8674071   Storchova Z and Pellman D (2004). From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 5: 45-54. http://dx.doi.org/10.1038/nrm1276 PMid:14708009   Strathdee G, Davies BR, Vass JK, Siddiqui N, et al. (2004). Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Carcinogenesis 25: 693-701. http://dx.doi.org/10.1093/carcin/bgh066 PMid:14729589   Wind T, Hansen M, Jensen JK and Andreasen PA (2002). The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment. Biol. Chem. 383: 21-36. http://dx.doi.org/10.1515/BC.2002.003 PMid:11928815   Wu C and Morris JR (2001). Genes, genetics, and epigenetics: a correspondence. Science 293: 1103-1105. http://dx.doi.org/10.1126/science.293.5532.1103 PMid:11498582   Xiao YP, Wu DY, Xu L and Xin Y (2006). Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma. World J. Gastroenterol. 12: 3766-3769. PMid:16773697   Yang YQ, Wu L, Chen JX, Sun JZ, et al. (2008). Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients. World J. Gastroenterol. 14: 5549-5556. http://dx.doi.org/10.3748/wjg.14.5549 PMid:18810774 PMCid:2746343